Kevin J. McHugh

Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID-19.

Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy.

Zero-order drug delivery: State of the art and future prospects.

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy.

Nanotechnology-enhanced immunotherapy for metastatic cancer.

Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness.

Bright, Magnetic NIR-II Quantum Dot Probe for Sensitive Dual-Modality Imaging and Intensive Combination Therapy of Cancer.

Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity.

Translating diagnostics and drug delivery technologies to low-resource settings.

Enhanced stability and clinical absorption of a form of encapsulated vitamin A for food fortification.

Dynamic Imine Bonding Facilitates Mannan Release from a Nanofibrous Peptide Hydrogel.

A Scalable Platform for Fabricating Biodegradable Microparticles with Pulsatile Drug Release.

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems.

Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization.